KHTRF

KNIGHT THERAPEUTICS INC by Knight Therapeutics Inc (KHTRF)

About KNIGHT THERAPEUTICS INC by Knight Therapeutics Inc (KHTRF)

Knight Therapeutics, Inc. engages in the business of acquiring, in licensing, out-licensing, marketing, and commercializing pharmaceuticals products. The firm also focuses on building a portfolio of innovative products through in-licensing or acquiring product rights. The company was founded by Jonathan Ross Goodman on November 1, 2013 and is headquartered in Montréal, Canada.

Details

Daily high
$6.70
Daily low
$6.70
Price at open
$6.70
52 Week High
$6.84
52 Week Low
$4.07
Market cap
657.8M
Dividend yield
0.00%
Volume
300
Avg. volume
14,010
P/E ratio
158.02

KNIGHT THERAPEUTICS INC by Knight Therapeutics Inc News

Details

Daily high
$6.70
Daily low
$6.70
Price at open
$6.70
52 Week High
$6.84
52 Week Low
$4.07
Market cap
657.8M
Dividend yield
0.00%
Volume
300
Avg. volume
14,010
P/E ratio
158.02